Medtronic Looks Beyond The World Of Doctors And Devices In New Approach To Markets
EMEA president on the value of Swiss HQ, putting the tech into medtech and readying for the commercial challenges ahead
Health warning to global medtechs: The world’s largest medical device company is taking steps to strengthen key account management, retain its market share hold and set up new health care partnerships.
You may also be interested in...
Medtech’s resilience and flexibility have been clear to see during the COVID-19 pandemic. In this forward-looking view for 2022, CEOs from some of the leading global medtechs share their perspectives on the present and the future, from company and health care system standpoints.
Exec Chat: Medtronic’s Linnea Burman Targets 'Consensus-Driven Care' Using AI, Robotics In Spine Care
Linnea Burman, the general manager of enabling technologies for cranial and spinal technologies at Medtronic, talked to Medtech Insight about plans for the Mazor spinal robotic system, the incoming new president of the division, and other new developments.
Medtronic’s robotic-assisted surgery system earned a CE mark approval for urologic and gynecologic procedures, which make up about half of all robotic procedures.